All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
PHASEBIO PHARMACEUTICALS INC Last Reported: 3/31/2024 Stock Symbol: PHASQ

Business Address

1 GREAT VALLEY PARKWAY
SUITE 30
MALVERN , PA US 19355

Mailing Address

1 GREAT VALLEY PARKWAY
SUITE 30
MALVERN , PA US 19355
Phone Number: (610) 981-6500 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 12/31/2016
Cash and Cash Equivalents $7,800,000.00 $41,800,000.00 $56,400,000.00 $64,500,000.00 $28,122,000.00 $39,400,000.00 $53,000,000.00 $59,400,000.00 $74,025,000.00 $81,771,000.00 $90,342,000.00 $51,894,000.00 $61,031,000.00 $24,341,000.00 -- -- $13,406,000.00 $4,277,000.00 $3,715,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,760,000.00 $6,984,000.00 $8,884,000.00 $5,644,000.00 $12,027,000.00 $10,595,000.00 $10,716,000.00 $12,204,000.00 $3,565,000.00 $1,015,000.00 $3,375,000.00 $1,491,000.00 $1,344,000.00 $216,000.00 -- -- $340,000.00 -- --
Total Current Assets $11,564,000.00 $48,784,000.00 $65,241,000.00 $88,500,000.00 $40,149,000.00 $49,948,000.00 $63,741,000.00 $72,541,000.00 $78,823,000.00 $83,369,000.00 $94,897,000.00 $54,075,000.00 $62,628,000.00 $24,968,000.00 -- -- $13,766,000.00 -- --
Property Plant and Equipement $9,322,000.00 $10,230,000.00 $10,841,000.00 $10,379,000.00 $8,224,000.00 $6,164,000.00 $4,876,000.00 $2,637,000.00 $1,924,000.00 $1,022,000.00 $677,000.00 $380,000.00 $355,000.00 $251,000.00 -- -- $302,000.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $58,000.00 $57,000.00 $57,000.00 $57,000.00 $57,000.00 $57,000.00 $57,000.00 $32,000.00 $32,000.00 $32,000.00 $32,000.00 $32,000.00 $43,000.00 $51,000.00 -- -- $31,000.00 -- --
Total Assets $22,166,000.00 $60,540,000.00 $77,725,000.00 $100,637,000.00 $50,357,000.00 $58,207,000.00 $70,810,000.00 $76,858,000.00 $82,494,000.00 $86,203,000.00 $97,438,000.00 $56,386,000.00 $63,026,000.00 $27,488,000.00 -- -- $14,099,000.00 -- --
Accounts Payable $6,320,000.00 $12,570,000.00 $8,521,000.00 $2,958,000.00 $3,674,000.00 $2,124,000.00 $6,967,000.00 $1,918,000.00 $2,921,000.00 $1,659,000.00 $3,047,000.00 $2,058,000.00 $1,806,000.00 $1,576,000.00 -- -- $430,000.00 -- --
Accrued Liabilities -- $8,353,000.00 -- -- $5,931,000.00 -- -- -- $3,180,000.00 -- -- -- $2,771,000.00 $2,987,000.00 -- -- $1,281,000.00 -- --
Total Current Liabilities $139,564,000.00 $153,574,000.00 $128,054,000.00 $119,812,000.00 $75,559,000.00 $53,855,000.00 $44,417,000.00 $23,372,000.00 $22,516,000.00 $15,399,000.00 $15,829,000.00 $12,304,000.00 $12,099,000.00 $18,053,000.00 -- -- $21,881,000.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- $7,500,000.00 -- $7,500,000.00 -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-419,600,000.00 $-391,794,000.00 $-348,684,000.00 $-316,800,000.00 $-260,700,000.00 $-230,348,000.00 $-205,205,000.00 $-177,063,000.00 $-162,158,000.00 $-150,827,000.00 $-139,436,000.00 $-130,204,000.00 $-122,911,000.00 $-118,043,000.00 -- -- $-99,065,000.00 -- --
Total Stockholders' Equity $-117,398,000.00 $-93,034,000.00 $-50,329,000.00 $-19,175,000.00 $-25,202,000.00 $4,352,000.00 $26,393,000.00 $53,486,000.00 $59,978,000.00 $70,804,000.00 $81,609,000.00 $44,082,000.00 $50,927,000.00 $-116,174,000.00 $-108,360,000.00 $-101,731,000.00 $-97,416,000.00 -- $-87,182,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $22,166,000.00 $60,540,000.00 $77,725,000.00 $100,637,000.00 $50,357,000.00 $58,207,000.00 $70,810,000.00 $76,858,000.00 $82,494,000.00 $86,203,000.00 $97,438,000.00 $56,386,000.00 $63,026,000.00 $27,488,000.00 -- -- $14,099,000.00 -- --

Statement of Operations

Date 6/30/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $35,275,000.00 $102,107,000.00 $25,066,000.00 $49,686,000.00 $72,088,000.00 $17,416,000.00 $20,856,000.00 $11,449,000.00 $30,911,000.00 $9,028,000.00 $13,502,000.00 $5,721,000.00 $15,455,000.00 $9,779,000.00 $5,425,000.00 $2,235,000.00 $6,210,000.00 $4,387,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $25,520,000.00 $118,193,000.00 $28,911,000.00 $57,038,000.00 $85,176,000.00 $20,492,000.00 $24,098,000.00 $14,608,000.00 $42,097,000.00 $11,831,000.00 $10,185,000.00 $8,037,000.00 $20,312,000.00 $5,410,000.00 $4,107,000.00 $2,878,000.00 $8,538,000.00 $6,087,000.00 --
Loss from Operations $-25,312,000.00 $-107,362,000.00 $-75,276,000.00 $-46,700,000.00 $-84,856,000.00 $-58,878,000.00 $-38,386,000.00 $-14,288,000.00 $-39,736,000.00 $-28,456,000.00 $-9,482,000.00 $-7,384,000.00 $-19,644,000.00 $-11,984,000.00 $-4,107,000.00 $-2,878,000.00 $-8,538,000.00 $-6,087,000.00 --
Loss Before Income Taxes $-16,665,000.00 $-129,471,000.00 $-31,924,000.00 $-54,437,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.57 $-2.98 $-0.66 $-1.41 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 49,182,813 43,918,996 42,499,685 39,680,408 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.57 $-2.98 $-2.07 $-1.41 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 49,182,813 43,918,996 48,046,307 39,680,408 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 20,789,273 -- -- 20,789,273 -- --
Common Stock Shares Outstanding 49,858,116 48,190,590 48,062,483 48,027,753 29,441,887 29,359,321 28,861,567 28,780,640 28,766,404 28,752,844 28,697,640 24,498,425 24,498,275 765,673 -- -- 745,788 -- --
Common Stock Value $50,000.00 $48,000.00 $48,000.00 $48,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00 $25,000.00 $25,000.00 $1,000.00 -- -- $1,000.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com